CellGenix
Freiburg, DE
Reagent / Material Supplier
Program data pending ClinicalTrials.gov matching
· Last scored 2026-10-29
56.5
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (1)
○ EMA GMP
○ MHRA GMP
Quick Facts: CellGenix
- Signal Score
- 56.5/100 (as of 2026-10-29)
- Quality Compliance
- Assessment pending
- Headquarters
- Freiburg, DE
- Modalities
- Cell Therapy
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About CellGenix
Reagent/raw material supplier.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesCell Therapy
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
53.0
1 manufacturing site: Freiburg, DE
Modalities: Cell Therapy
Capacity assessment: 53.0/100
Sites: Freiburg, DE
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
Press Signals1 articles (not scored)
1 manufacturing site: Freiburg, DE
Modalities: Cell Therapy
Capacity assessment: 53.0/100
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No count for this company yet. The careers board we can read covers more than this business, and we can't yet tell which of those roles belong to it. Why: board unreadable today: error. We'd rather show no number than one that isn't really this company's.
Source:
sartorius.wd3.myworkdayjobs.com
· Checked Nov 20, 2026
Company Signals 1 articles
Company announcements, not verified evidence. They do not change any score.
GMP Cytokines Market to Grow at 8.4% CAGR Through 2032 | Bio-Techne, PeproTech, CellGenix, Miltenyi Biotec - openPR.com
GMP Cytokines Market to Grow at 8.4% CAGR Through 2032 | Bio-Techne, PeproTech, CellGenix, Miltenyi Biotec openPR.com
Frequently Asked Questions About CellGenix
What is CellGenix's CDMO Signal Score?
CellGenix has a Signal Score of 56/100, based on quality, operations, financial stability, and capacity data.
Evaluating CellGenix for a manufacturing program?
Use the free AI matchmaker to compare CellGenix against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Minaris Advanced Therapies
Philadelphia, PA · Allendale, NJ · Munich, DE · Yokohama, JP
Signal Score: 83.1
CAR-T, Cell Therapy
Merck KGaA / MilliporeSigma (CDMO)
Darmstadt, DE · St. Louis, MO
Signal Score: 81.9
mRNA, Biologics, Cell Therapy
Eurofins CDMO
Planegg, DE · San Diego, CA
Signal Score: 81.6
Biologics, Cell Therapy
Bristol Myers Squibb (CGT Mfg)
Bothell, WA · Warren, NJ
Signal Score: 87.0
CAR-T, Cell Therapy
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 86.3
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
Compare CellGenix with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.